IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 56 filers reported holding IMMUNIC INC in Q3 2023. The put-call ratio across all filers is 15.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,258 | -87.2% | 3,577 | -78.2% | 0.00% | – |
| Q2 2023 | $41,192 | +6.3% | 16,411 | -36.9% | 0.00% | – |
| Q1 2023 | $38,734 | +92.6% | 25,996 | +81.0% | 0.00% | – |
| Q4 2022 | $20,110 | -98.8% | 14,364 | -97.2% | 0.00% | – |
| Q3 2022 | $1,610,000 | -8.9% | 509,380 | -0.0% | 0.00% | – |
| Q2 2022 | $1,768,000 | -69.3% | 509,552 | -0.1% | 0.00% | – |
| Q1 2022 | $5,765,000 | +18.3% | 510,148 | +0.2% | 0.00% | – |
| Q4 2021 | $4,875,000 | -48.3% | 509,372 | -52.2% | 0.00% | -100.0% |
| Q3 2021 | $9,427,000 | -35.5% | 1,065,289 | -10.7% | 0.00% | 0.0% |
| Q2 2021 | $14,623,000 | -22.6% | 1,192,722 | +0.6% | 0.00% | -50.0% |
| Q1 2021 | $18,895,000 | -6.4% | 1,185,342 | -10.2% | 0.00% | 0.0% |
| Q4 2020 | $20,192,000 | +9.1% | 1,320,542 | +32.5% | 0.00% | 0.0% |
| Q3 2020 | $18,504,000 | +1012.7% | 996,470 | +626.3% | 0.00% | – |
| Q2 2020 | $1,663,000 | – | 137,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,788,160 | $2,628,595 | 2.41% |
| Gratus Capital, LLC | 1,686,455 | $2,479,089 | 0.17% |
| INNOVIS ASSET MANAGEMENT LLC | 272,457 | $400,512 | 0.15% |
| Parkman Healthcare Partners LLC | 562,506 | $826,884 | 0.15% |
| RTW INVESTMENTS, LP | 4,335,255 | $6,372,825 | 0.13% |
| Logos Global Management LP | 421,184 | $619,140 | 0.08% |
| Ikarian Capital, LLC | 450,000 | $661,501 | 0.08% |
| BVF INC/IL | 1,149,425 | $1,689,655 | 0.05% |
| Soleus Capital Management, L.P. | 300,000 | $441,000 | 0.04% |
| COWEN AND COMPANY, LLC | 317,059 | $466,076 | 0.03% |